Business
Idaho Falls site added to RTX-2358 manufacturing plan
PharmaLogic will expand production capacity for Ratio Therapeutics’ Ac-225 RTX-2358 as the FAP-targeted radiopharmaceutical moves through ATLAS clinical testing.
Company
Ratio Therapeutics